Explore the healthcare RCM market in 2026, including end-to-end outsourcers, billing firms, BPO providers, AI automation, prior authorization, denials, and buyer trends.
Published September 16, 2026 by the Services Tech Review Editorial Team
The healthcare revenue cycle management market has never been more segmented, more contested, or more technically complex than it is in 2026. Denial volumes are climbing, regulatory mandates around prior authorization are reshaping operational infrastructure, and private equity is reshaping ownership across every vendor category. This guide maps the market as it stands today, who competes where, what forces are driving change, and how buyer organizations are structuring their sourcing decisions. For foundational definitions, see our related reading: What Is Revenue Cycle Management and How Does It Work and How We Evaluate RCM and Medical Billing Providers.
The healthcare RCM vendor landscape is not a single market, it is a layered set of overlapping categories, each serving different buyer needs and workflow stages. Understanding how these segments relate to one another is essential before evaluating any specific vendor. Five segments define the current competitive map.
At the top of the market sit a small number of large-scale managed services organizations that assume operational responsibility for the full revenue cycle on behalf of hospitals and health systems. These relationships are typically structured as long-term contracts where the vendor's staff operate within, or alongside, the health system's own workflows.
Several of the largest delivery systems, Ascension, HCA, Tenet, and Bon Secours Mercy, have spun their internal RCM functions into subsidiary or co-owned companies (R1, Parallon, Conifer, and Ensemble, respectively) and sell services to other providers. The result is a market where the dominant end-to-end outsourcers trace their origins to health system operations rather than to software development, which shapes their delivery culture and contract structures.
The large health system market is largely spoken for, Ensemble, Optum, R1, and Conifer have those relationships locked. R1 RCM, Ensemble Health Partners, Optum (through its Optum Insight division), and Conifer Health Solutions are the most frequently cited names in this segment. Each competes on scale, operational depth, and increasingly on the degree to which AI is embedded into their managed service delivery.
While R1 RCM focuses on operational efficiency through proprietary technology, Optum leverages its massive scale and integrated payer-provider data. Ensemble has carved out a strong position in nonprofit and community health system accounts. Conifer, after Tenet regained full ownership in early 2026, is building its AI infrastructure in partnership with Google Cloud, automating tasks currently handled by hundreds of Conifer staff, including verification of eligibility and benefits, processing prior authorization documents, assigning and validating codes, predicting denials, following up on claims, and generating appeals.
The scale of consolidation in this segment is evident in Clayton, Dubilier & Rice and TowerBrook Capital Partners' $8.9 billion take-private acquisition of R1 RCM, a deal that reinforced the attractiveness of end-to-end RCM platforms to private equity.
Distinct from the managed services outsourcers, a second segment consists of software platforms that sell directly to health systems, hospital groups, and physician enterprises. These vendors do not take operational responsibility for billing outcomes in the same managed-service sense; they provide the technology infrastructure that providers use to run their own revenue cycle teams, or on which outsourcers build their delivery.
Waystar is one of the most prominent names in this space, offering cloud-based revenue cycle automation with strong capabilities in claims management, eligibility verification, and, increasingly, AI-native workflow orchestration. Waystar competes in the revenue cycle automation space, focusing on cloud-based financial performance, with an emphasis on AI-driven software to streamline claims and payments.
Experian Health occupies a strong position in patient access and coverage discovery. athenahealth (now part of Athenahealth, Inc.) serves ambulatory and physician group markets with an EHR-integrated RCM platform. Oracle Health (the successor to Cerner's health IT business) and Epic's RCM modules operate within the EHR ecosystem, giving them a structural advantage for health systems already standardized on those platforms. Oracle/Cerner and Microsoft/Nuance embed RCM into EHRs, threatening to bypass third-party vendors by offering end-to-end workflows within clinician systems.
FinThrive and Waystar represent a category of independent RCM platform vendors that position themselves as EHR-agnostic alternatives, competing on integration breadth and automation capabilities.
Below the large enterprise segment sits a large, fragmented tier of billing companies that serve specific clinical specialties, practice types, or care settings. These companies differentiate through deep domain expertise rather than scale but on specialty-specific expertise: knowledge of payer behavior within a particular specialty, familiarity with specialty-specific coding complexity, and experience navigating the reimbursement rules that apply to specific services.
This segment covers physician practices (including independent groups and MSO-affiliated practices), behavioral health and mental health providers, dental practices, clinical laboratories, ambulatory surgery centers, and federally qualified health centers. Physician groups, behavioral health providers, FQHCs, specialty practices, and surgery centers each face distinct coding, authorization, and payer-contracting dynamics that generalist billers often handle less effectively than specialty-focused firms.
The growth edge in the independent practice and ambulatory surgery center segment is significant, consolidation is still early and pricing power exists. This observation partly explains why private equity capital continues to flow into this tier alongside the large end-to-end segment. Specialty billing companies that have built defensible workflow expertise in behavioral health, for example, or in laboratory billing, are relatively attractive acquisition targets.
A distinct category of vendor provides the workforce capacity that powers many RCM operations, at both health systems and billing companies, without necessarily owning the end-to-end relationship with the provider. These offshore and nearshore business process outsourcing (BPO) firms handle high-volume, process-intensive tasks: medical coding, accounts receivable follow-up, denial management, payment posting, and eligibility verification.
Coding, billing, and denials management can be sent offshore or nearshore because those functions do not require U.S. licensure or physical presence. Major players in this segment include AGS Health, Omega Healthcare, Access Healthcare, and CorroHealth. AGS Health codes more than 54 million charts and processes $53 billion in accounts receivables each year, offering patient access services, health information management and clinical services, AI agents and intelligent automation, various coding types, analytics and reporting, and more.
CorroHealth embeds coding teams, CDI specialists, and denial analysts into provider operations, backed by proprietary AI and a global workforce of 17,000+. Backed by Carlyle Group and co-owned by Patient Square Capital, CorroHealth sits at the intersection of PE capital, offshore labor arbitrage, and clinical documentation technology.
A notable geographic shift is underway within this segment. The shift is going from offshore to nearshore, with time-zone alignment with Latin American delivery centers supporting real-time prior authorization and denials work. India leads healthcare BPO with the largest pool of certified medical coders and billers and mature HIPAA compliance infrastructure; the Philippines is the second-largest hub, offering native English fluency; and nearshore options like Mexico and Colombia offer onshore time zones with moderate cost savings. The choice between delivery geographies is increasingly a function of the specific work being outsourced, not just cost.
The fifth and fastest-moving segment consists of technology vendors that do not operate the full revenue cycle but provide AI capabilities that sit on top of existing EHRs, practice management systems, or outsourced delivery models. These vendors target specific high-friction workflow points: prior authorization, medical coding assistance, denial prediction, AR prioritization, and appeals generation.
Providers apply AI to eligibility verification, prior authorization, coding assistance, denial prediction, A/R prioritization, appeals generation, and payment-variance analysis. AKASA has built its identity around AI-native RCM automation for health systems, with particular attention to authorization workflows and denial management. Infinx operates a hybrid model combining AI with specialist human follow-up, organized around its Healthcare Revenue Cloud platform. Infinx focuses on revenue cycle efficiency through an effective blend of AI, automation, and human expertise, built on Healthcare Revenue Cloud, an interoperable backbone that orchestrates AI, automation, and human agents into a unified, scalable solution.
Other vendors in this segment include Cohere Health (prior authorization), Fathom and RapidClaims (AI coding), Janus Health (RCM automation), and SmarterDx (revenue integrity). The segment is growing quickly through venture funding and strategic acquisition. Waystar has also moved aggressively here, with capabilities recognized across agentic AI and autonomous revenue cycle workflows.
Six structural forces are reshaping how the RCM market operates, how vendors position, and how buyers make decisions.
Healthcare revenue cycle leaders are facing a rapidly shifting landscape in 2026. Between new prior authorization mandates, escalating payer scrutiny, Medicare reimbursement changes, AI-driven workflows, and climbing denial volumes, practices can no longer manage the revenue cycle the way they did even a few years ago.
54% of RCM leaders report rising claim errors, and 41% report that at least 1 in 10 claims are denied, reflecting widespread concern about denial management heading into 2026. Medical necessity reviews are increasing, and many payers are relying more heavily on automated adjudication systems that can deny claims based on missing or inconsistent data. The overturn rate on denied claims remains high, suggesting that many denials are not clinically justified on the merits, but appealing them requires administrative capacity that many organizations do not have.
Prior authorization has become the defining operational challenge of the current RCM environment. Prior authorization has become one of the clearest points where administrative complexity directly affects patient care. For health systems, it is no longer just a utilization management tool, it shapes access, delays therapy, and increasingly defines the operational and technology infrastructure required to deliver care.
The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) took operational effect on January 1, 2026. Compliance with new CMS rules, including FHIR-based electronic prior authorization systems, strict turnaround times of 7 days standard and 72 hours urgent, and expanded reporting requirements, adds complexity for every provider organization. API requirements under the rule are phased, with most payers required to meet the full electronic prior authorization API specifications by January 1, 2027.
In April 2026, CMS extended its reform agenda further. Released in April 2026, the drug prior authorization proposal expands reform beyond nondrug items and services directly into drugs covered under both medical and pharmacy benefits, introducing requirements for electronic prior authorization, shorter decision timelines, more specific denial explanations, and standardized data exchange.
Workforce shortages remain a significant challenge. Hospitals continue to experience staffing constraints in patient access, coding, billing, denial management, and collections. MGMA workforce data continues to show persistent administrative staffing shortages and burnout trends across healthcare operations.
The staffing shortage is simultaneously a problem and a driver of demand for outsourcing and automation. More than half of revenue cycle leaders said they expect their RCM operations to be less effective unless they make changes fast, citing rising denials and appeals volumes, claims processing inefficiencies, aging accounts receivable, and labor and skills shortages as the biggest barriers to improvement.
An HFMA/AKASA survey found 80% of health systems were exploring, piloting, or implementing generative AI for RCM in 2025, up from 58% in 2023. The direction is clear, but actual deployment remains uneven. While three out of four executives are currently implementing or have used AI in various functions, 59% of respondents said they haven't yet implemented AI or automation in the revenue cycle, and just 2% said they've fully or mostly integrated these technologies across their RCM operations.
Health systems are increasingly deploying AI for denial prediction, claim scrubbing, coding assistance, and workflow prioritization, but AI cannot independently resolve complex payer disputes, interpret nuanced clinical documentation for appeals, or navigate emotionally sensitive patient financial conversations. The practical picture is of a technology that is genuinely useful in high-volume, rules-based tasks but that still requires human judgment for exception handling, complex clinical documentation review, and payer negotiation.
Regulators and legal authorities are also increasing scrutiny over AI use in claims adjudication, medical necessity reviews, and patient communications, meaning healthcare organizations must ensure that AI-driven processes comply with federal and state regulations while maintaining appropriate human oversight.
The RCM market is in a sustained period of consolidation driven by private equity capital. The healthcare RCM sector is experiencing significant merger and acquisition activity, with private equity firms and strategic acquirers actively pursuing acquisitions of RCM companies, deploying capital with a focused interest in companies that offer AI-driven automation, scalable technology, and strong financial performance.
Large healthcare IT vendors are actively acquiring RCM firms to integrate AI, automation, and risk adjustment tools into their solutions rather than building in-house capabilities. At the same time, the mid-market and lower-middle market remain highly fragmented, creating ongoing opportunity for platform roll-up strategies targeting physician group and ambulatory surgery center billing companies.
The ongoing transition from traditional fee-for-service models to more complex value-based care models with quality-and-outcome-based reimbursements requires fundamental changes to an organization's RCM processes. Value-based arrangements require capturing quality metrics, managing attribution, and tracking outcome data in ways that traditional billing infrastructure was never designed to support.
Hospitals are under increasing pressure to comply with stricter price transparency regulations. These rules require providers to publish comprehensive pricing data for services and procedures, creating operational and technological challenges for many organizations, and failure to meet these requirements can result in financial penalties, reputational damage, and patient dissatisfaction. Price transparency obligations add a front-end compliance layer to RCM that interacts with patient access, scheduling, and financial counseling workflows.
Buyer organizations in 2026 think about RCM sourcing along three primary dimensions.
Fully insourced RCM, where the provider organization employs its own billing and coding staff, manages its own denial workflows, and operates its own technology stack, remains the baseline for most large academic medical centers and integrated delivery networks. Fully outsourced models, where an end-to-end outsourcer like R1 or Ensemble assumes operational control, are common among health systems seeking to reduce administrative overhead or access capabilities they cannot build internally. Hospitals and health systems are outsourcing RCM to reduce costs, offset staffing shortages, improve billing accuracy, accelerate cash flow, and gain access to specialized expertise and automation technologies that are difficult to build internally.
The hybrid model, where core strategy and oversight remain internal but specific functions (coding, prior auth, AR follow-up) are outsourced to BPO providers or point-solution vendors, is becoming increasingly common. It allows organizations to maintain control while accessing labor arbitrage and specialized automation. 30-nine percent of healthcare executives said they're implementing point solutions in the revenue cycle, which reflects this hybrid tendency.
The full-cycle vs. point-solution axis is separate from the insource/outsource question. A health system can outsource its entire RCM to a single end-to-end managed services provider, or it can assemble a stack of best-of-breed point solutions that each address a specific workflow, eligibility, coding, prior auth, denials, and integrate them with the EHR. Automation is accelerating, with health systems increasingly deploying AI for denial prediction, claim scrubbing, coding assistance, and workflow prioritization, typically via point solutions layered on the existing environment. The integration overhead of a multi-vendor stack is real, but so is the flexibility it provides.
Several trends in the market are substantive. The CMS regulatory shift around prior authorization is real and operational, providers and payers are actively restructuring workflows to comply. The staffing shortage is structural and not resolving quickly. AI adoption in specific high-volume tasks (eligibility verification, coding assist, denial triage) is delivering measurable results in early adopter organizations. Nearshore BPO growth in Latin America reflects genuine operational advantages in time-zone alignment for denial-sensitive work.
What remains at the hype stage is the notion of a fully autonomous revenue cycle. Automation alone cannot deliver resilience. Offshore alone cannot deliver differentiation. But an integrated model that aligns AI, global talent, governance, and empathy can. The organizations achieving the most measurable progress are those combining AI-enabled automation with trained human oversight, not those replacing the latter entirely with the former. The vision for 2026 is clear: organizations must leverage technology to move beyond AI awareness to seamless integration of AI in daily workflows, but for large-scale AI adoption, vendors must think critically about how to infuse it into provider workflows with transparency and without creating additional challenges.
The healthcare RCM market can be divided into five functional segments: large end-to-end outsourcers serving health systems (such as R1 RCM, Ensemble Health Partners, Optum, and Conifer); RCM technology and software platforms (such as Waystar, Experian Health, athenahealth, Oracle Health, and Epic's RCM modules); specialty-focused medical billing companies serving physician practices, behavioral health providers, dental offices, and laboratories; offshore and nearshore BPO providers handling coding, AR follow-up, and denial management (such as AGS Health, Omega Healthcare, Access Healthcare, and CorroHealth); and AI/automation vendors layered on top of existing infrastructure (such as AKASA and Infinx).
The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) took operational effect on January 1, 2026, introducing mandatory turnaround timelines for standard and urgent prior authorization decisions and requiring payers to publish authorization metrics publicly. Impacted payers are required to implement certain provisions by January 1, 2026, while they have until primarily January 1, 2027, to meet the full API requirements. A proposed rule issued in April 2026 extends the electronic prior authorization framework to cover drugs under both medical and pharmacy benefits, adding another layer of compliance complexity for both payers and providers.
Workforce shortages remain a significant challenge, with hospitals continuing to experience staffing constraints in patient access, coding, billing, denial management, and collections. These shortages are accelerating both outsourcing decisions, as organizations turn to BPO and managed services providers to fill capacity gaps, and AI adoption, as vendors and health systems attempt to automate the tasks that are hardest to staff. The shortage is particularly acute in medical coding, where certified coder supply has not kept pace with the complexity and volume of coding work driven by new payer requirements.
The insource/outsource decision depends on organizational scale, existing technology infrastructure, tolerance for vendor dependency, and specific workflow pain points. Large health systems with mature internal teams often move toward hybrid models, retaining strategic oversight internally while outsourcing specific high-volume functions like coding or prior authorization follow-up to BPO providers or point-solution AI vendors. Smaller physician groups and specialty practices frequently outsource more comprehensively, given the difficulty of maintaining billing expertise internally across the full spectrum of payer rules. The decision is rarely binary; most organizations land somewhere on a spectrum.
Providers are actively applying AI to eligibility verification, prior authorization, coding assistance, denial prediction, A/R prioritization, appeals generation, and payment-variance analysis. However, adoption is uneven. Just 2% of healthcare executives say they've fully or mostly integrated AI or automation across their RCM operations, and roughly 60% haven't yet implemented any AI or automation in their revenue cycle operations. The organizations achieving genuine results are applying AI to specific, well-defined workflow problems with appropriate human oversight, not attempting to automate the entire cycle at once.
As healthcare providers struggle with rising administrative costs, payer rules, and increased patient financial responsibility, there is heightened demand for efficient, technology-enabled RCM solutions, and PE firms see durable, recurring revenue in the companies that deliver those solutions. The market remains highly fragmented below the large enterprise tier, creating a meaningful consolidation runway. Vendors that combine automation-driven efficiencies with scalable technology and diversified client bases are attracting the highest valuations and the most acquisition interest.
Editorial Note
This guide is produced by the ServicesTechReview editorial team. No provider has paid for inclusion or placement.